The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of antiemetic prophylaxis and oral breakthrough medication for highly emetogenic chemotherapy (HEC) in a large community oncology network.
 
Garrett Young
Employment - OneOncology
 
Stephen Matthew Schleicher
Employment - Tennessee Oncology
Leadership - OneOncology
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Magnolia Innovation; Rigel
Research Funding - Tennessee Oncology
Travel, Accommodations, Expenses - Flatiron Health; Magnolia Innovation; Rigel; Tennessee Oncology
 
Edward Arrowsmith
Employment - Tennessee Oncology
Stock and Other Ownership Interests - OneOncology
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calistoga Pharmaceuticals (Inst); Celgene (Inst); Cephalon (Inst); Chorus (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Eisai (Inst); EMD Serono (Inst); Evelo Biosciences (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen Research & Development (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Modra Pharmaceuticals (Inst); Novartis (Inst); Oncogenex (Inst); Onyx (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Sarah Cannon Research Institute (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Flatiron Health; OneOncology; Sarah Cannon Research Institute
Other Relationship - Sarah Cannon Research Institute
 
Stacey McCullough
Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Blueprint Medicines; Daiichi Sankyo; Epizyme; G1 Therapeutics; GlaxoSmithKline; Immunomedics; Verastem
Speakers' Bureau - Teva
 
Sylvia S. Richey
No Relationships to Disclose
 
Johnetta Blakely
No Relationships to Disclose
 
Natalie R. Dickson
Employment - Tennessee Oncology
Consulting or Advisory Role - Abbvie; Synergy Health (Hong Kong) Limited; Via Oncology
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Flatiron Health; Flatiron Health
 
Lee S. Schwartzberg
Honoraria - Amgen; AstraZeneca; Bayer; E.R. Squibb Sons, LLC; Genentech; Genomic Health; Helsinn Healthcare; Myriad Genetics; Napo Pharmaceuticals; Pfizer; Spectrum Pharmaceuticals
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech; Genomic Health; Helsinn Therapeutics; Myriad Genetics; Napo Pharmaceuticals; Pfizer; Spectrum Pharmaceuticals
Research Funding - Amgen (Inst)